The effects of IL-10 on proinflammatory cytokine expression (IL-1β and IL-8) in hyaline membrane disease (HMD)

Clinical Immunology and Immunopathology

Volumn 88, Issue 1, 1998, Pages 105-113

  Kwong, K Y C ^a   Jones, C A ^a   Cayabyab, R ^a   Lecart, C ^a   Khuu, N ^a   Rhandhawa, I ^a   Hanley, J M ^a   Ramanathan, R ^a   Delemos, R A ^a   Minoo, P ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

Hyaline membrane disease; IL 10; IL 1b; IL 8; Lipopolysaccharide

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; RECOMBINANT INTERLEUKIN 10;

ACUTE RESPIRATORY FAILURE; ARTICLE; HUMAN; HUMAN CELL; HYALINE MEMBRANE DISEASE; IMMUNOREGULATION; INFLAMMATORY CELL; LUNG LAVAGE; PATHOGENESIS; PREMATURITY; PRIORITY JOURNAL;

EID: 0031875586     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4510     Document Type: Article

References (34)

1. Ogden B. E., Murphy S., Saunders G. C., Johnson J. D. Lung lavage of newborns with respiratory distress syndrome: Prolonged neutrophil influx is associated with bronchopulmonary dysplasia. Chest. 83:1983;31-33.
2. Bonikos D. S., Bensch K. G., Merit T. A. Bronchopulmonary Dysplasia Northway. 1988;Blackwell, Boston. p. 33-58.
3. Edwards D. K., Colby T. V., Northway W. H. Radiographic-pathologic correlation in bronchopulmonary dysplasia. J. Pediatr. Radiol. 95:1979;834-836.
4. Rozycki H. J. Bronchoalveolar lavage interleukin-1β in infants on day 1 of life. South. Med. J. 87:1994;991-996.
5. Groneck P., Gotae-Speer B., Oppermann M., Eiffert H., Speer C. P. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: A sequential analysis of inflammatory mediators in respiratory fluids of high risk preterm neonates. Pediatrics. 93:1994;712-718.
6. Bagchi A., Viscardi R. M., Taciak V., Ensor J. E., McCrea K. A., Hasday J. D. Increased activity of interleukin-6 but not tumor necrosis factor-α in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr. Res. 36:1994;244-252.
7. Jones C. A., Cayabyab R. G., Kwong K. Y. C., Stotts C., Wong B., Hamdan H., Minoo P., deLemos R. A. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for predisposition to chronic lung inflammation in preterm newborns. Pediatr. Res. 39:1996;966-975.
8. de Waal Malefyt R., Abrams J., Bennett B., Figdor C. G., deVries J. E. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes. J. Exp. Med. 174:1991;1209-1220.
9. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
10. Hebert C. A., Baker J. B. Interleukin-8 - A review. Cancer Invest. 116:1993;743-750.
11. Old L. Tumor necrosis factor (TNF). Science. 230:1985;630-632.
12. Platanias L., Vogelzang N. Interleukin-1: Biology, pathophysiology and clinical prospects. Am. J. Med. 89:1990;621-629.
13. Lun W. W., Christ J. W. ARDS: Appreciating the causes, making the diagnosis. J. Respir. Dis. 16:1995;581-590.
14. Chernoff A. E., Granowitz E. V., Shapiro L., Vannier E., Lonnemann G., Angel J. B., Kennedy J. S., Rabson A. R., Wolff S. M., Dinarello C. A. A randomnized, controlled trial of IL-10 in humans. J. Immunol. 154:1995;5492-5499.
15. Danders R. J., Cox C., Phelps D. L., Sinkin R. A. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr. Res. 36:1994;122-128.
16. Yeh T. F., Torre J. A., Rastogi A., Anyebuno M. A., Pildse R. S. Early postnatal dexamothasone therapy in premature infants with severe respiratory distress syndrome; a double-blind, controlled study. J. Pediatr. 117:1990;273-283.
17. Cash J. M., Hoffman G. S. Rich R. R. Clinical Immunology. 1996;1947-1958 Mosby, St. Louis.
18. Am. Rev. Respir. Dis. 148:1993;1105-1108.
19. Khalil N., O'Connor R. N., Unruh H. W., Warren P. W., Flanders K. C. Increased production and Immunohistochemical localization of transforming growth factor β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 5:1991;155-162.
20. Kwong K. Y. C., Jones C. A., Cayabyab R., Lecart C., Stotts C. L., Randhawa I., Ramanathan R., Khuu N., Minoo P., deLemos R. A. Differential regulation of IL-8 by IL-1b and TNFa in hyaline membrane disease (HMD). J. Clin. Immunol. 1998.
21. Little S., Dean T., Bevin S., Hall M., Ashton, Church M., Warner J., Shute J. Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 as markers of chronic lung disease in premature infants. Thorax. 50:1995;1073-1079.
22. Kotecha S., Wilson L., Wangoo A., Silverman M., Shaw R. J. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr. Res. 40:1996;250-256.
23. Kotecha S., Chan B., Azam N., Siverman M., Shaw R. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch. Dis. Child. 72:1995;F90-F96.
24. Chheda S., Palkowetz K. H., Garofalo R., Rassin D. K., Goldman A. S. Decreased interleukin-10 production by neonatal monocytes and T cells: Relationship to decreased production and expression of tumor necrosis factor-a and its receptors. Pediatr. Res. 40:1996;475-483.
25. Berg D. J., Davidson N., Kuhn R., Muller W., Menon S., Holland G., Thompson-Snipes L., Leach M. W., Rennick D. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Invest. 98:1996;1010-1020.
26. Borish L., Aarons A., Rumbyrt J., Cvietusa P., Negri J., Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. 97:1996;1288-1296.
27. Marchant A., Alegre M. L., Hakim A., Pierard G., Marcaux G., Friedman G., De Groote D., Kahn R. J., Vincent J. L., Goldman M. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J. Clin. Immunol. 15:1995;266-273.
28. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays the onset of autoimmunity in NZB/F1 mice. J. Exp. Med. 179:1994;305-310.
29. Ishida H., Hastings R., Thompson-Snipes L., Howard M. Modified immunological status of anti-IL-10 treated mice. Cell. Immunol. 148:1993;371-384.
30. Ishida H. Clinical implications of IL-10 in patients with immune and inflammatory diseases. Lymphokine Cytokine Res. 12:1993.
31. Schreiber S., Heinig T., Thiele H. G., Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology. 108:1995;1434-1444.
32. Marchant A., Bruyns C., Vandenabeele P., Ducarme M., Gerard C., Delvaux A., De Groote D., Abrowicz D., Velu T., Goldman M. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur. J. Immunol. 24:1994;1167-1171.
33. Barnes P. J. Appreciating the role of airway inflammation in asthma. J. Respir. Dis. 15:1994;S7-S18.
34. Frankenberger M., Pechumer H., Ziegler-Heitbrock H. W. Interleukin-10 is upregulated in LPS tolerance. J. Inflamm. 45:1995;56-63.